Vascular Biogenics Ltd (NASDAQ:VBLT)
| 1.54 BATS BZX Real-Time Price As of 10:41am ET |  -0.03 / -1.91%Today’s Change | 1.10 Today|||52-Week Range 2.59 | -21.83% Year-to-Date |
Latest VBLT News | Press Releases
No recent news for Vascular Biogenics Ltd.
Today’s Trading
| Previous close | 1.57 |
| Today’s open | 1.64 |
| Day’s range | 1.54 - 1.64 |
| Volume | 1,091 |
| Average volume (3 months) | 146,149 |
| Market cap | $103.3M |
Data as of 10:41am ET, 06/29/2022
Growth & Valuation
| Earnings growth (last year) | +18.71% |
| Earnings growth (this year) | -8.44% |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | -16.70% |
| P/E ratio | NM |
| Price/Sales | 170.19 |
| Price/Book | 2.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CFRXContraFect Corp | +0.10 | +3.56% |
| LPTXLeap Therapeutics In... | -0.05 | -3.67% |
| FIXXHomology Medicines I... | -0.01 | -0.52% |
| ---- |
Data as of 12:59pm ET, 06/29/2022
Financials
| Next reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $768.0K |
| Annual profit (last year) | -$29.9M |
| Net profit margin | -3,895.83% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Modi’in, Jerusalem |
Forecasts
